Gene · 9757
Papers2,805
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,805
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours. | Int J Mol Sci | 2023 | 37686260 | PubTator, text mining | PubMed |
| Histone demethylase KDM6A coordinating with KMT2B regulates self-renewal and chemoresistance of non-small cell lung cancer stem cells. | Transl Oncol | 2023 | 37683307 | PubTator, text mining | PubMed |
| ClinPrior: an algorithm for diagnosis and novel gene discovery by network-based prioritization. | Genome Med | 2023 | 37679823 | PubTator, text mining | PubMed |
| Identification of the H3K36me3 reader LEDGF/p75 in the pancancer landscape and functional exploration in clear cell renal cell carcinoma. | Comput Struct Biotechnol J | 2023 | 37675289 | PubTator, text mining | PubMed |
| To stay in shape and keep moving: MLL emerges as a new transcriptional regulator of Rho GTPases. | Small GTPases | 2023 | 37671980 | PubTator, text mining | PubMed |
| Integrated analysis of the ubiquitination mechanism reveals the specific signatures of tissue and cancer. | BMC Genomics | 2023 | 37667177 | PubTator, text mining | PubMed |
| A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer. | Nat Cancer | 2023 | 37640930 | PubTator, text mining | PubMed |
| New twists of a TAIL: novel insights into the histone binding properties of a highly conserved PHD finger cluster within the MLR family of H3K4 mono-methyltransferases. | Nucleic Acids Res | 2023 | 37638761 | PubTator, text mining | PubMed |
| Generalized Dystonia Due to KMT2B Mutation in a Patient with a Previous Diagnosis of Russell Silver Syndrome. | Mov Disord Clin Pract | 2023 | 37636227 | PubTator, text mining | PubMed |
| Aicardi Syndrome Is a Genetically Heterogeneous Disorder. | Genes (Basel) | 2023 | 37628618 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| Demethylase-independent roles of LSD1 in regulating enhancers and cell fate transition. | Nat Commun | 2023 | 37607921 | PubTator, text mining | PubMed |
| Whole exome sequencing and clinical investigation of young onset dystonia: What can we learn? | Parkinsonism Relat Disord | 2023 | 37607452 | PubTator, text mining | PubMed |
| Species-specific roles for the MAFA and MAFB transcription factors in regulating islet β cell identity. | JCI Insight | 2023 | 37606041 | PubTator, text mining | PubMed |
| Epigenetic Regulation of the Expression of T Cell Stimulatory and Inhibitory Factors by Histone H3 Lysine Modification Enzymes and Its Prognostic Roles in Glioblastoma. | J Korean Med Sci | 2023 | 37605497 | PubTator, text mining | PubMed |
| Extensive analysis of 59 sarcoma-related fusion genes identified pazopanib as a potential inhibitor to COL1A1-PDGFB fusion gene. | Cancer Sci | 2023 | 37592448 | PubTator, text mining | PubMed |
| The diversified role of mitochondria in ferroptosis in cancer. | Cell Death Dis | 2023 | 37580393 | PubTator, text mining | PubMed |
| Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses. | BMC Oral Health | 2023 | 37573343 | PubTator, text mining | PubMed |
| Epigenetic Factors and ncRNAs in Testicular Cancer. | Int J Mol Sci | 2023 | 37569569 | PubTator, text mining | PubMed |
| H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. | J Immunother Cancer | 2023 | 37553181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9757/papers?page=12